# EDGAR Filing Document

**Accession Number:** 0000785161
**File Stem:** 0001127602-23-007400
**Filing Date:** 2023-2
**Character Count:** 9068
**Document Hash:** e788a9155e4c014114f0c34f39161eb1
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001127602-23-007400.hdr.sgml**: 20230228

**ACCESSION NUMBER**: 0001127602-23-007400

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20230224

**FILED AS OF DATE**: 20230228

**DATE AS OF CHANGE**: 20230228

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Charbonneau Elissa Joy
- **CENTRAL INDEX KEY:** 0001647458

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-10315
- **FILM NUMBER:** 23680148

**MAIL ADDRESS:**
- **STREET 1:** 24 HAWTHORNE CIRCLE
- **CITY:** YARMOUTH
- **STATE:** ME
- **ZIP:** 04096
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Encompass Health Corp
- **CENTRAL INDEX KEY:** 0000785161
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-HOSPITALS [8060]
- **IRS NUMBER:** 630860407
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 9001 LIBERTY PARKWAY
- **CITY:** BIRMINGHAM
- **STATE:** AL
- **ZIP:** 35242
- **BUSINESS PHONE:** 205-967-7116

**MAIL ADDRESS:**
- **STREET 1:** 9001 LIBERTY PARKWAY
- **CITY:** BIRMINGHAM
- **STATE:** AL
- **ZIP:** 35242

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** HEALTHSOUTH CORP
- **DATE OF NAME CHANGE:** 19950113

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** HEALTHSOUTH REHABILITATION CORP
- **DATE OF NAME CHANGE:** 19920703

## Ex-24

```

POWER OF ATTORNEY

	Know all men by these presents that the undersigned hereby
constitutes and appoints Patrick Darby and Stephen Leasure,
and each of them individually, the undersigned's true
and lawful attorney-in-fact to:

       (1) 	execute for and on behalf of the undersigned,
in the capacity as an officer and/or director of Encompass
Health Corporation, a Delaware corporation (the "Company"),
Forms 3, 4 and 5, Schedule 13D and Schedule 13G and amendments
thereto in accordance with Sections 13(d) and 16(a) of the
Securities Exchange Act of 1934 and the rules thereunder,
and any other forms or reports the undersigned may be
required to file in connection with the undersigned's
ownership, acquisition, or disposition of securities
of the Company;

       (2)	do and perform any and all acts for
and on behalf of the undersigned which may be necessary
or desirable to complete the execution of any such Form 3,
4 or 5, Schedule 13D, Schedule 13G, or other form or
report, and timely file such form, schedule or report
with the United States Securities and Exchange Commission
and any other authority; and

	(3)	take any other action of any type whatsoever
in connection with the foregoing which, in the opinion of
each such attorney-in-fact, may be of benefit to, in the
best interest of, or legally required by, the undersigned,
it being understood that the documents executed by such
attorney-in-fact on behalf of the undersigned pursuant
to this Power of Attorney shall be in such form and
shall contain such terms and conditions as such
attorney-in-fact may approve in his or her discretion.

	The undersigned hereby grants to each such
 attorney-in-fact full power and authority to do
and perform all and every act and thing whatsoever
requisite, necessary and proper to be done in the
exercise of any of the rights and powers herein
granted, as fully to all intents and purposes
as the undersigned might or could do if personally
present, with full power of substitution or revocation,
and hereby ratifies and confirms all that such attorney-in-fact,
or his or her substitute or substitutes, shall lawfully
do or cause to be done by virtue of this Power of Attorney
and the rights and powers herein granted. The undersigned
acknowledges that the foregoing attorney-in-fact, in serving
in such capacity at the request of the undersigned, is
not assuming any of the undersigned's responsibilities
to comply with Sections 13(d) and 16 of the Securities
Exchange Act of 1934.

	This Power of Attorney shall remain in
full force and effect until the undersigned is n
o longer required to file Forms 3, 4, and 5, Schedule 13D,
Schedule 13G, or other form or report with respect to
the undersigned's holdings of and transactions in securities
issued by the Company, unless revoked by the undersigned
in a signed writing delivered to each foregoing attorney-in fact.

	IN WITNESS WHEREOF, the undersigned has caused
this Power of Attorney to be executed effectively as of
this 24th day of January 2023.

            /S/ ELISSA CHARBONNEAU
Elissa Charbonneau

```

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Charbonneau Elissa Joy<br><sub>(Last) (First) (Middle)</sub><br>317 LOWER FLYING POINT ROAD<br><sub>(Street)</sub><br>FREEPORT, ME 04032<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2023-02-24 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_Chief Medical Officer_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Encompass Health Corp [ EHC ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Encompass Health Common Stock | 2023-02-24 |  | F |  | 356<sup>(1)</sup> | D | $60.22 | 31881.061 | D |  |
| Encompass Health Common Stock | 2023-02-27 |  | F |  | 506<sup>(1)</sup> | D | $60.22 | 31375.061 | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |

---

### Footnotes:

(1) These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock.

**Signature:** /s/ Patrick Darby, attorney-in-fact for Ms. Charbonneau  
**Date:** 2023-02-27

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**